These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 9605771)
1. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771 [TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients]. Zhou Q; Liang LJ; Peng BG; Zhen YY Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916 [TBL] [Abstract][Full Text] [Related]
3. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells. Tavian D; Salvi A; De Petro G; Barlati S Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199 [TBL] [Abstract][Full Text] [Related]
4. Expression of urokinase-type plasminogen activator receptor in hepatocellular carcinoma. Morita Y; Hayashi Y; Wang Y; Kanamaru T; Suzuki S; Kawasaki K; Ohta K; Yamamoto M; Saitoh Y; Itoh H; Doe WF Hepatology; 1997 Apr; 25(4):856-61. PubMed ID: 9096588 [TBL] [Abstract][Full Text] [Related]
5. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
6. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Paciucci R; Torà M; Díaz VM; Real FX Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108 [TBL] [Abstract][Full Text] [Related]
7. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens. Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385 [TBL] [Abstract][Full Text] [Related]
8. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma. Dubuisson L; Monvoisin A; Nielsen BS; Le Bail B; Bioulac-Sage P; Rosenbaum J J Pathol; 2000 Feb; 190(2):190-5. PubMed ID: 10657018 [TBL] [Abstract][Full Text] [Related]
9. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder. Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521 [TBL] [Abstract][Full Text] [Related]
10. Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases. Sier CF; Quax PH; Vloedgraven HJ; Verheijen JH; Griffioen G; Ganesh S; Lamers CB; Verspaget HW Invasion Metastasis; 1993; 13(6):277-88. PubMed ID: 7860221 [TBL] [Abstract][Full Text] [Related]
11. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells. Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589 [TBL] [Abstract][Full Text] [Related]
12. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. Piedagnel R; Tiger Y; Lelongt B; Ronco PM J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905 [TBL] [Abstract][Full Text] [Related]
13. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. de Vries TJ; Kitson JL; Silvers WK; Mintz B Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649 [TBL] [Abstract][Full Text] [Related]
15. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Oszajca K; Bieniasz M; Brown G; Swiatkowska M; Bartkowiak J; Szemraj J Biochem Cell Biol; 2008 Dec; 86(6):477-86. PubMed ID: 19088796 [TBL] [Abstract][Full Text] [Related]
16. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein. Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664 [TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator. Jankun J; Maher VM; McCormick JJ Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659 [TBL] [Abstract][Full Text] [Related]
18. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients]. Xiao W; Tong WL; Ma DD Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049 [TBL] [Abstract][Full Text] [Related]
19. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708 [TBL] [Abstract][Full Text] [Related]
20. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]